AKIRIN2 Antikörper (Cy5)
Kurzübersicht für AKIRIN2 Antikörper (Cy5) (ABIN1418604)
Target
Alle AKIRIN2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human AKIRIN2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IF(IHC-P) 1:50-200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- AKIRIN2 (Akirin 2 (AKIRIN2))
-
Andere Bezeichnung
- AKIRIN2
-
Hintergrund
-
Synonyms: AKIR2_HUMAN, AKIRIN 2, Akirin-2, Akirin2, C6orf166, dJ486L4.2, FBI1, FLJ10342, Fourteen three three beta interactant 1.
Background: Required for the innate immune response. Downstream effector of the Toll-like receptor (TLR), TNF and IL-1 beta signaling pathways leading to the production of IL-6. Forms a complex with YWHAB that acts to repress transcription of DUSP1.
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-